San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

OncoSec Medical to Partner With Merck on Clinical Study

San Diego’s OncoSec Medical Inc. has entered a research collaboration with Merck & Co., one of the largest pharmaceutical companies in the world.

By Brittany Meiling May 11, 2017 5:04 p.m. share »

Michael Rodriguez Named CFO at GenomeDx Biosciences

GenomeDx Biosciences just recruited Michael Rodriguez, the guy who secured Epic Sciences’ recent $40 million round, to lead the genomics company as chief financial officer.

By Brittany Meiling May 9, 2017 2:49 p.m. share »

DexCom Announces $350 Million Offering

DexCom Inc. announced that it is raising $350 million to settle debts and finance growth and manufacturing.

By Brittany Meiling May 9, 2017 2:35 p.m. share »
Tease photo

Illumina’s C-Suite Met With Chinese Officials

Illumina’s top executives are building ties with the Chinese government as the San Diego company expands into the massive Chinese health care market.

By Brittany Meiling May 8, 2017 11:25 a.m. share »

AmpliPhi Biosciences Stock Price Tumbles 59 Percent Following Equity Offering Announcement

The stock price for local biotech AmpliPhi Biosciences was down 59 percent at market close May 5 following news that the company is raising $10.4 million in an equity offering.

By Brittany Meiling May 5, 2017 2:32 p.m. share »

AMN Healthcare's Q1 Earnings Up 24%

San Diego-based AMN Healthcare Services Inc. reported first-quarter earnings of $32 million, up 24 percent compared with the same quarter last year.

By Sarah de Crescenzo May 5, 2017 1:44 p.m. share »
Tease photo

Are BIO and Startup Week Heading for a Scheduling Conflict?

Local biotech startups will have to choose between two major events taking place in June, as both annual conferences are scheduled in the same week.

By Brittany Meiling May 5, 2017 11:47 a.m. share »
Tease photo

Neurocrine Prices Pills High, Revenues to Ramp in 2018

Neurocrine Biosciences Inc. has priced its new medicine on the high end of the spectrum, topping all previous estimates for the drug’s annual cost to patients.

By Brittany Meiling May 4, 2017 2:17 p.m. share »

Ignyta Announces $76.9 Million Stock Offering

Ignyta Inc., a local company working on anti-cancer therapies, is raising $76.9 million in a stock offering.

By Brittany Meiling May 4, 2017 2:03 p.m. share »
Tease photo

Steven Chen Promoted to CMO at Avelas Biosciences

Avelas Biosciences Inc., a cancer diagnostic company, has promoted Dr. Steven Chen to serve as the company’s chief medical officer.

By Brittany Meiling May 4, 2017 1:52 p.m. share »
Tease photo

Diagnostic to Guide Late-Stage Cancer Treatment

Armed with $40 million in fresh capital, Epic Sciences Inc. is ramping up development of tests that show how well cancer patients will respond — or not respond — to anti-cancer treatments.

By Brittany Meiling May 4, 2017 1:28 p.m. share »

DexCom's Q1 Revenues Fall Short of Projections

Stock is down nearly 10 percent Wednesday for San Diego device maker DexCom Inc. following an earnings report that left some investors unimpressed.

By Brittany Meiling May 3, 2017 4:40 p.m. share »

HLI Just Snatched Up 4 GE Execs

San Diego’s growing health intelligence company, Human Longevity Inc., has recruited four executives from GE Healthcare to lead the company’s commercialization efforts.

By Brittany Meiling May 3, 2017 1:41 p.m. share »

Orexigen Subsidiary Signs Deal With Swedish Distributor

A subsidiary of local drugmaker Orexigen Therapeutics Inc. has signed a deal with Navamedic AB, a Swedish distributor, to commercialize one of its products in five Nordic countries.

By Brittany Meiling May 2, 2017 1:03 p.m. share »

Big Pharma Execs Join Renova Leadership Team

Renova Therapeutics Inc., a local biotech developing gene and peptide therapies, has recruited two Big Pharma executives to join the biotech’s leadership team.

By Brittany Meiling May 2, 2017 10:53 a.m. share »